Successful Treatment of Small-Cell Lung Cancer With Irinotecan in a Hemodialysis Patient With End-Stage Renal Disease
The Korean Journal of Internal Medicine
; : 73-75, 2009.
Article
ي En
| WPRIM
| ID: wpr-12975
المكتبة المسؤولة:
WPRO
ABSTRACT
The prognosis of patients with end-stage renal disease has improved with advances in hemodialysis techniques. However, many patients who undergo hemodialysis suffer from various types of cancer. Limited data is available to guide clinical management of these patients who may have impaired renal function. Here, we report our experience with the use of irinotecan for the treatment of a hemodialysis patient with small-cell lung cancer and end-stage renal disease.
Key words
النص الكامل:
1
الفهرس:
WPRIM
الموضوع الرئيسي:
Camptothecin
/
Follow-Up Studies
/
Renal Dialysis
/
DNA Topoisomerases, Type I
/
Disease-Free Survival
/
Small Cell Lung Carcinoma
/
Kidney Failure, Chronic
/
Lung Neoplasms
/
Antineoplastic Agents, Phytogenic
نوع الدراسة:
Observational_studies
/
Prognostic_studies
المحددات:
Humans
/
Male
اللغة:
En
مجلة:
The Korean Journal of Internal Medicine
السنة:
2009
نوع:
Article